Cronos Group Inc. (NASDAQ:CRON) is one of the top high growth Canadian stocks to buy, with a strong balance sheet holding $824 million in cash and no debt. In Q3 2025, Cronos reported record net revenue of $36.3 million, driven by the success of the Spinach brand in the cannabis market.

Cronos Group Inc. (NASDAQ:CRON) is a globally diversified cannabis company with operations on four continents. Despite its potential as an investment, some AI stocks may offer greater upside potential and lower downside risk. For an undervalued AI stock with growth potential, check out our free report on the best short-term AI stock.

Analysts reiterated a Hold rating on Cronos Group Inc. (NASDAQ:CRON) with a price target of $2.30, in line with consensus. Cronos’ Phase 2 expansion at GrowCo is expected to support additional growth in 2026. While Cronos stands out in the cannabis industry, other AI stocks may offer more significant opportunities.

For more investment options, check out our articles on the 13 Best Dividend Kings to Buy in 2026 and the 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now. Disclosure: None.

Read more at Yahoo Finance: Bernstein Reiterates Hold on Cronos Group Inc. (CRON) as Cash-Rich Balance Sheet Stands Out